Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

David Lye

Showing results (11-20 of 40) with videos related to

Pageof 4
Sort By:
The Journal of Infectious Diseases|March 4, 2015
Association Between Increased Vascular Nitric Oxide Bioavailability and Progression to Dengue Hemorrhagic Fever in AdultsTun-Linn Thein, Joshua Wong, Yee-Sin Leo, et al.
Trials|November 2, 2013
Oral versus intravenous antibiotics for patients with Klebsiella pneumoniae liver abscess: study protocol for a randomized controlled trialJames Molton, Rachel Phillips, Mihir Gandhi, et al.
JAMA Network Open|November 10, 2023
mRNA SARS-CoV-2 Vaccination Before vs During Pregnancy and Omicron Infection Among InfantsOrlanda Goh, Deanette Pang, Janice Tan, et al.
Antimicrobial Agents and Chemotherapy|May 18, 2021
Epidemiology and Transmission of Carbapenemase-Producing <i>Enterobacteriaceae</i> in a Health Care Network of an Acute-Care Hospital and Its Affiliated Intermediate- and Long-Term-Care Facilities in SingaporeAung-Hein Aung, Kala Kanagasabai, Jocelyn Koh, et al.
Trials|December 8, 2021
Investigator-Driven Randomised Controlled Trial of Cefiderocol versus Standard Therapy for Healthcare-Associated and Hospital-Acquired Gram-negative Bloodstream Infection: Study protocol (the GAME CHANGER trial): study protocol for an open-label, randomised controlled trialHugh Wright, Patrick N A Harris, Mark D Chatfield, et al.
Trials|June 20, 2014
Vancomycin versus daptomycin for the treatment of methicillin-resistant Staphylococcus aureus bacteremia due to isolates with high vancomycin minimum inhibitory concentrations: study protocol for a phase IIB randomized controlled trialShirin Kalimuddin, Rachel Phillips, Mihir Gandhi, et al.
AJPM Focus|November 10, 2025
Impact of Vaccination-Differentiated Public Health and Social Measures on Vaccine Uptake Among the Vaccine HesitantEn Jie Tan, Cheryl Chong, Alex Yap, et al.
The Journal of Infection|December 4, 2012
Risk factors and treatment outcome of ertapenem non-susceptible enterobacteriaceae bacteraemiaKalisvar Marimuthu, Tat Ming Ng, Christine Teng, et al.
Clinical Infectious Diseases : an Official Publication of the Infectious Diseases Society of America|June 26, 2024
Risks of SARS-CoV-2 JN.1 Infection and COVID-19-Associated Emergency Department Visits/Hospitalizations Following Updated Boosters and Prior Infection: A Population-Based Cohort StudyCheryl Chong, Liang En Wee, Xuan Jin, et al.
PLOS Global Public Health|March 24, 2023
Estimating the economic cost of carbapenem resistant Enterobacterales healthcare associated infections in Singapore acute-care hospitalsYiying Cai, Grace S R Hoo, Winnie Lee, et al.
Pageof 4

Showing results (11-20 of 40) with videos related to

Sort By:
Pageof 4
The Journal of Infectious Diseases|March 4, 2015
Association Between Increased Vascular Nitric Oxide Bioavailability and Progression to Dengue Hemorrhagic Fever in AdultsTun-Linn Thein, Joshua Wong, Yee-Sin Leo, et al.
Trials|November 2, 2013
Oral versus intravenous antibiotics for patients with Klebsiella pneumoniae liver abscess: study protocol for a randomized controlled trialJames Molton, Rachel Phillips, Mihir Gandhi, et al.
JAMA Network Open|November 10, 2023
mRNA SARS-CoV-2 Vaccination Before vs During Pregnancy and Omicron Infection Among InfantsOrlanda Goh, Deanette Pang, Janice Tan, et al.
Antimicrobial Agents and Chemotherapy|May 18, 2021
Epidemiology and Transmission of Carbapenemase-Producing <i>Enterobacteriaceae</i> in a Health Care Network of an Acute-Care Hospital and Its Affiliated Intermediate- and Long-Term-Care Facilities in SingaporeAung-Hein Aung, Kala Kanagasabai, Jocelyn Koh, et al.
Trials|December 8, 2021
Investigator-Driven Randomised Controlled Trial of Cefiderocol versus Standard Therapy for Healthcare-Associated and Hospital-Acquired Gram-negative Bloodstream Infection: Study protocol (the GAME CHANGER trial): study protocol for an open-label, randomised controlled trialHugh Wright, Patrick N A Harris, Mark D Chatfield, et al.
Trials|June 20, 2014
Vancomycin versus daptomycin for the treatment of methicillin-resistant Staphylococcus aureus bacteremia due to isolates with high vancomycin minimum inhibitory concentrations: study protocol for a phase IIB randomized controlled trialShirin Kalimuddin, Rachel Phillips, Mihir Gandhi, et al.
AJPM Focus|November 10, 2025
Impact of Vaccination-Differentiated Public Health and Social Measures on Vaccine Uptake Among the Vaccine HesitantEn Jie Tan, Cheryl Chong, Alex Yap, et al.
The Journal of Infection|December 4, 2012
Risk factors and treatment outcome of ertapenem non-susceptible enterobacteriaceae bacteraemiaKalisvar Marimuthu, Tat Ming Ng, Christine Teng, et al.
Clinical Infectious Diseases : an Official Publication of the Infectious Diseases Society of America|June 26, 2024
Risks of SARS-CoV-2 JN.1 Infection and COVID-19-Associated Emergency Department Visits/Hospitalizations Following Updated Boosters and Prior Infection: A Population-Based Cohort StudyCheryl Chong, Liang En Wee, Xuan Jin, et al.
PLOS Global Public Health|March 24, 2023
Estimating the economic cost of carbapenem resistant Enterobacterales healthcare associated infections in Singapore acute-care hospitalsYiying Cai, Grace S R Hoo, Winnie Lee, et al.
Pageof 4